Syed A Rizvi: Medical Scoring Systems – Small Numbers, Big Clinical Decisions
Syed A Rizvi, Public Health Program Specialist at Illinois Department of Public Health (IDPH), shared on LinkedIn:
”Medical Scoring Systems: Small Numbers, Big Clinical Decisions
Every day, clinicians make complex decisions under conditions of uncertainty.
Medical scoring systems help transform patient data into actionable insights, supporting evidence-based care while improving consistency and communication across healthcare teams.
Some of the most widely used scoring systems include:
- Cardiology and Stroke Prevention
- CHA₂DS₂-VASc – Estimates stroke risk in patients with atrial fibrillation and guides anticoagulation decisions.
- HAS-BLED – Assesses bleeding risk in patients receiving anticoagulant therapy.
Critical Care and Emergency Medicine
- APACHE II – Predicts mortality risk in critically ill ICU patients.
- Glasgow Coma Scale (GCS) – Evaluates neurological status following trauma, stroke, or altered mental status.
Hematology and Thromboembolism
- Wells Score – Estimates the probability of deep vein thrombosis (DVT) or pulmonary embolism (PE), guiding further diagnostic testing.
Internal Medicine and Pulmonology
- CURB-65 – Helps determine the severity of community-acquired pneumonia and the need for hospitalization.
- MELD Score – Assesses the severity of chronic liver disease and helps prioritize liver transplant candidates.
Sepsis and Surgical Care
- qSOFA – A rapid bedside screening tool for identifying patients at risk of poor outcomes from sepsis.
- Child-Pugh Score – Evaluates prognosis and disease severity in cirrhosis.
As healthcare increasingly embraces artificial intelligence and predictive analytics, these scoring systems remain foundational tools for risk stratification and clinical decision-making.
Yet they are exactly that—tools, not substitutes for clinical judgment.
The best outcomes occur when evidence-based algorithms are combined with experience, critical thinking, and patient-centered care.”

Stay updated with Hemostasis Today.
-
Jul 14, 2026, 19:35Daratumumab in Difficult-to-Treat iTTP: Updated Results from the International DarTTP Study
-
Jul 14, 2026, 17:1610 Posts Not To Miss from ISTH 2026, Part 3
-
Jul 14, 2026, 15:27Dianne E Van Der Wal: Celebrating Scientific Contributions at ISTH 2026
-
Jul 14, 2026, 15:13Alfonso Tafur: RIETE Registry Analysis Supports More Equitable Approaches to VTE Care
-
Jul 14, 2026, 15:03Heghine Khachatryan: Phase III Trial Results Support BAFF-R Inhibition in Corticosteroid-Refractory ITP
-
Jul 14, 2026, 14:51Nathan Connell: ISTH 2026 Highlights the Power of Lifelong Collaboration
-
Jul 14, 2026, 14:42Wolfgang Miesbach: VOYAGER1 Highlights Progress Toward Injection-Free Care in Hemophilia A
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026